KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Accumulated Expenses: 2018-2025

Historic Accumulated Expenses for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $31.3 million.

  • Twist Bioscience's Accumulated Expenses fell 7.02% to $31.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year decrease of 7.02%. This contributed to the annual value of $31.3 million for FY2025, which is 7.02% down from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Accumulated Expenses is $31.3 million, which was down 7.02% from $33.6 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Accumulated Expenses registered a high of $33.6 million during FY2024, and its lowest value of $22.3 million during FY2021.
  • Over the past 3 years, Twist Bioscience's median Accumulated Expenses value was $31.3 million (recorded in 2025), while the average stood at $30.3 million.
  • In the last 5 years, Twist Bioscience's Accumulated Expenses surged by 49.39% in 2021 and then declined by 7.02% in 2025.
  • Twist Bioscience's Accumulated Expenses (Yearly) stood at $22.3 million in 2021, then rose by 21.03% to $27.0 million in 2022, then declined by 4.46% to $25.8 million in 2023, then skyrocketed by 30.34% to $33.6 million in 2024, then fell by 7.02% to $31.3 million in 2025.